Le Lézard1h
DATROWAY® Approved in the U.S. for Patients with Previously Treated Metastatic HR Positive, HER2 Negative Breast Cancer
DATROWAY® (datopotamab deruxtecan-dlnk) has been approved in the U.S. for the treatment of adult patients with unresectable or metastatic hormone receptor (HR) positive, HER2 negative (IHC 0, IHC 1+ ...
Le Lézard23h
Heparin Market to Grow by USD 3.34 Billion (2024-2028), Driven by Rising Prevalence of Coagulation Disorders; AI-Powered Market Evolution - Technavio
Report on how AI is driving market transformation - The global heparin market  size is estimated to grow by USD 3.34 billion from 2024-2028, according to Technavio. The market is estimated to grow at ...
Sepsis molecule discovery could lead to improved treatments for critically ill patients
Researchers at Oregon Health & Science University have uncovered how a molecule found on certain bacteria may drive blood ...
pulmonologyadvisor8h
Study Suggests Lanadelumab Effective as LTP in Patients With HAE
Lanadelumab has been found to be effective as long-term prophylaxis in reducing attack frequency in patients with HAE.
Amgen: FDA Approves Lumakras (sotorasib) In Combination With Vectibix (panitumumab) For Chemorefractory Kras G12c-mutated Metastatic Colorectal Cancer
Pivotal Study Demonstrated the Combination More Than Doubled Progression-Free Survival Compared to Investigated SOC THOUSAND OAKS, Calif., Jan. 17, 2025 /PRNewswire/ ...